According to literature, beyond CD49d there are numerous cell surface markers (i.e. CD69, CD184, CD185, CD27, and CD86) which may have prognostic or predictive relevance in CLL. This evidence concerns the gene CD86 and B-cell chronic lymphocytic leukemia.